Global Percutaneous Coronary Intervention (PCI) Devices Market Growth 2024-2030

Publication ID:

LPI12246717

Publication Date:

December 24, 2024

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Percutaneous Coronary Intervention (PCI) Devices market size was valued at US$ 4881.2 million in 2023. With growing demand in downstream market, the Percutaneous Coronary Intervention (PCI) Devices is forecast to a readjusted size of US$ 6239.1 million by 2030 with a CAGR of 3.6% during review period.
The research report highlights the growth potential of the global Percutaneous Coronary Intervention (PCI) Devices market. Percutaneous Coronary Intervention (PCI) Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Percutaneous Coronary Intervention (PCI) Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Percutaneous Coronary Intervention (PCI) Devices market.
Percutaneous coronary intervention (PCI) is a non-surgical procedure, in which a catheter is used to place stent to broaden the narrowed coronary arteries.
The rapid shift toward MIS and increase in the volume of PCI procedures will be one of the primary growth drivers for the global percutaneous coronary intervention (PCI) devices market till 2021.
Key Features:
The report on Percutaneous Coronary Intervention (PCI) Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Percutaneous Coronary Intervention (PCI) Devices market. It may include historical data, market segmentation by Type (e.g., Coronary Stents, PTCA Catheters), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Percutaneous Coronary Intervention (PCI) Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Percutaneous Coronary Intervention (PCI) Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Percutaneous Coronary Intervention (PCI) Devices industry. This include advancements in Percutaneous Coronary Intervention (PCI) Devices technology, Percutaneous Coronary Intervention (PCI) Devices new entrants, Percutaneous Coronary Intervention (PCI) Devices new investment, and other innovations that are shaping the future of Percutaneous Coronary Intervention (PCI) Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Percutaneous Coronary Intervention (PCI) Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Percutaneous Coronary Intervention (PCI) Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Percutaneous Coronary Intervention (PCI) Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Percutaneous Coronary Intervention (PCI) Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Percutaneous Coronary Intervention (PCI) Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Percutaneous Coronary Intervention (PCI) Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Percutaneous Coronary Intervention (PCI) Devices market.
Market Segmentation:
Percutaneous Coronary Intervention (PCI) Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Coronary Stents
PTCA Catheters
Coronary Guidewires
Embolic Protection Devices
Segmentation by application
Hospitals
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Abbott
Medtronic
Cordis
Terumo Medical
AMG International
ASAHI INTECC
B. Braun Melsungen
BioSensors
BIOTRONIK
BrosMed Medical
Claret Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Percutaneous Coronary Intervention (PCI) Devices market?
What factors are driving Percutaneous Coronary Intervention (PCI) Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Percutaneous Coronary Intervention (PCI) Devices market opportunities vary by end market size?
How does Percutaneous Coronary Intervention (PCI) Devices break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Percutaneous Coronary Intervention (PCI) Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Country/Region, 2019, 2023 & 2030
2.2 Percutaneous Coronary Intervention (PCI) Devices Segment by Type
2.2.1 Coronary Stents
2.2.2 PTCA Catheters
2.2.3 Coronary Guidewires
2.2.4 Embolic Protection Devices
2.3 Percutaneous Coronary Intervention (PCI) Devices Sales by Type
2.3.1 Global Percutaneous Coronary Intervention (PCI) Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Percutaneous Coronary Intervention (PCI) Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Percutaneous Coronary Intervention (PCI) Devices Sale Price by Type (2019-2024)
2.4 Percutaneous Coronary Intervention (PCI) Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinic
2.4.3 Other
2.5 Percutaneous Coronary Intervention (PCI) Devices Sales by Application
2.5.1 Global Percutaneous Coronary Intervention (PCI) Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Percutaneous Coronary Intervention (PCI) Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Percutaneous Coronary Intervention (PCI) Devices Sale Price by Application (2019-2024)
3 Global Percutaneous Coronary Intervention (PCI) Devices by Company
3.1 Global Percutaneous Coronary Intervention (PCI) Devices Breakdown Data by Company
3.1.1 Global Percutaneous Coronary Intervention (PCI) Devices Annual Sales by Company (2019-2024)
3.1.2 Global Percutaneous Coronary Intervention (PCI) Devices Sales Market Share by Company (2019-2024)
3.2 Global Percutaneous Coronary Intervention (PCI) Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Percutaneous Coronary Intervention (PCI) Devices Revenue by Company (2019-2024)
3.2.2 Global Percutaneous Coronary Intervention (PCI) Devices Revenue Market Share by Company (2019-2024)
3.3 Global Percutaneous Coronary Intervention (PCI) Devices Sale Price by Company
3.4 Key Manufacturers Percutaneous Coronary Intervention (PCI) Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Percutaneous Coronary Intervention (PCI) Devices Product Location Distribution
3.4.2 Players Percutaneous Coronary Intervention (PCI) Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region
4.1 World Historic Percutaneous Coronary Intervention (PCI) Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Percutaneous Coronary Intervention (PCI) Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Percutaneous Coronary Intervention (PCI) Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Percutaneous Coronary Intervention (PCI) Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Percutaneous Coronary Intervention (PCI) Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Percutaneous Coronary Intervention (PCI) Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Percutaneous Coronary Intervention (PCI) Devices Sales Growth
4.4 APAC Percutaneous Coronary Intervention (PCI) Devices Sales Growth
4.5 Europe Percutaneous Coronary Intervention (PCI) Devices Sales Growth
4.6 Middle East & Africa Percutaneous Coronary Intervention (PCI) Devices Sales Growth
5 Americas
5.1 Americas Percutaneous Coronary Intervention (PCI) Devices Sales by Country
5.1.1 Americas Percutaneous Coronary Intervention (PCI) Devices Sales by Country (2019-2024)
5.1.2 Americas Percutaneous Coronary Intervention (PCI) Devices Revenue by Country (2019-2024)
5.2 Americas Percutaneous Coronary Intervention (PCI) Devices Sales by Type
5.3 Americas Percutaneous Coronary Intervention (PCI) Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Percutaneous Coronary Intervention (PCI) Devices Sales by Region
6.1.1 APAC Percutaneous Coronary Intervention (PCI) Devices Sales by Region (2019-2024)
6.1.2 APAC Percutaneous Coronary Intervention (PCI) Devices Revenue by Region (2019-2024)
6.2 APAC Percutaneous Coronary Intervention (PCI) Devices Sales by Type
6.3 APAC Percutaneous Coronary Intervention (PCI) Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Percutaneous Coronary Intervention (PCI) Devices by Country
7.1.1 Europe Percutaneous Coronary Intervention (PCI) Devices Sales by Country (2019-2024)
7.1.2 Europe Percutaneous Coronary Intervention (PCI) Devices Revenue by Country (2019-2024)
7.2 Europe Percutaneous Coronary Intervention (PCI) Devices Sales by Type
7.3 Europe Percutaneous Coronary Intervention (PCI) Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Percutaneous Coronary Intervention (PCI) Devices by Country
8.1.1 Middle East & Africa Percutaneous Coronary Intervention (PCI) Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Percutaneous Coronary Intervention (PCI) Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Percutaneous Coronary Intervention (PCI) Devices Sales by Type
8.3 Middle East & Africa Percutaneous Coronary Intervention (PCI) Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Percutaneous Coronary Intervention (PCI) Devices
10.3 Manufacturing Process Analysis of Percutaneous Coronary Intervention (PCI) Devices
10.4 Industry Chain Structure of Percutaneous Coronary Intervention (PCI) Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Percutaneous Coronary Intervention (PCI) Devices Distributors
11.3 Percutaneous Coronary Intervention (PCI) Devices Customer
12 World Forecast Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region
12.1 Global Percutaneous Coronary Intervention (PCI) Devices Market Size Forecast by Region
12.1.1 Global Percutaneous Coronary Intervention (PCI) Devices Forecast by Region (2025-2030)
12.1.2 Global Percutaneous Coronary Intervention (PCI) Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Percutaneous Coronary Intervention (PCI) Devices Forecast by Type
12.7 Global Percutaneous Coronary Intervention (PCI) Devices Forecast by Application
13 Key Players Analysis
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.1.3 Boston Scientific Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.2.3 Abbott Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.3.3 Medtronic Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Cordis
13.4.1 Cordis Company Information
13.4.2 Cordis Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.4.3 Cordis Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cordis Main Business Overview
13.4.5 Cordis Latest Developments
13.5 Terumo Medical
13.5.1 Terumo Medical Company Information
13.5.2 Terumo Medical Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.5.3 Terumo Medical Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Terumo Medical Main Business Overview
13.5.5 Terumo Medical Latest Developments
13.6 AMG International
13.6.1 AMG International Company Information
13.6.2 AMG International Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.6.3 AMG International Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 AMG International Main Business Overview
13.6.5 AMG International Latest Developments
13.7 ASAHI INTECC
13.7.1 ASAHI INTECC Company Information
13.7.2 ASAHI INTECC Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.7.3 ASAHI INTECC Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 ASAHI INTECC Main Business Overview
13.7.5 ASAHI INTECC Latest Developments
13.8 B. Braun Melsungen
13.8.1 B. Braun Melsungen Company Information
13.8.2 B. Braun Melsungen Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.8.3 B. Braun Melsungen Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 B. Braun Melsungen Main Business Overview
13.8.5 B. Braun Melsungen Latest Developments
13.9 BioSensors
13.9.1 BioSensors Company Information
13.9.2 BioSensors Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.9.3 BioSensors Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 BioSensors Main Business Overview
13.9.5 BioSensors Latest Developments
13.10 BIOTRONIK
13.10.1 BIOTRONIK Company Information
13.10.2 BIOTRONIK Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.10.3 BIOTRONIK Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 BIOTRONIK Main Business Overview
13.10.5 BIOTRONIK Latest Developments
13.11 BrosMed Medical
13.11.1 BrosMed Medical Company Information
13.11.2 BrosMed Medical Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.11.3 BrosMed Medical Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 BrosMed Medical Main Business Overview
13.11.5 BrosMed Medical Latest Developments
13.12 Claret Medical
13.12.1 Claret Medical Company Information
13.12.2 Claret Medical Percutaneous Coronary Intervention (PCI) Devices Product Portfolios and Specifications
13.12.3 Claret Medical Percutaneous Coronary Intervention (PCI) Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Claret Medical Main Business Overview
13.12.5 Claret Medical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂